银屑病患者中的白细胞介素17、炎症与心血管风险
本综述探讨银屑病与心血管疾病的关联,重点分析白细胞介素17介导的炎症作为潜在机制联系,并描述降低银屑病患者心血管疾病负担的潜在治疗方法及两种疾病关联对患者管理和教育的临床重要性。
要点
- 银屑病是系统性疾病,与心血管疾病风险增加相关。
- 白细胞介素17介导的炎症可能是银屑病与心血管疾病的机制联系。
- 综述讨论了降低银屑病患者心血管疾病负担的潜在治疗方法。
核心结论
- 银屑病与心血管疾病风险增加相关,白细胞介素17介导的炎症可能是两者之间的潜在机制联系。
研究设计与样本
- 综述,未报告检索范围。
主要发现
- 银屑病患者合并症负担更高、预期寿命更短,尤其是早发型和重度患者。
- 心血管疾病是银屑病患者发病和死亡的最常见原因。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In addition to being recognized as a chronic inflammatory disease that manifests in the skin, psoriasis is increasingly understood to be a systemic disease that causes immune dysregulation throughout the body. The systemic nature of psoriasis is evidenced by the higher burden of comorbidities and shorter life expectancies of patients with psoriasis, particularly those with early-onset and severe disease. Notably, psoriasis is associated with an increased risk for cardiovascular disease, which is the most common cause of morbidity and mortality in patients with psoriasis. In this review, we examine the association between psoriasis and cardiovascular disease and specifically focus on the role of interleukin 17-mediated inflammation as a potential mechanistic link between psoriasis and cardiovascular disease. Moreover, we describe potential treatment approaches to reduce the burden of cardiovascular disease in patients with psoriasis and discuss the clinical importance of the association of these 2 diseases with respect to patient management and education.
引用
- Lockshin B, Balagula Y, Merola JF, et al. Interleukin 17, inflammation, and cardiovascular risk in patients with psoriasis. J Am Acad Dermatol. 2018. PMID: 29477740. doi:10.1016/j.jaad.2018.02.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。